A pilot study of treatment of lentigo maligna with 5% imiquimod cream

C. J. Fleming; A. M. Bryden; A. Evans; R. S. Dawe; S. H. Ibbotson

doi:10.1111/j.1365-2133.2004.05983.x

A pilot study of treatment of lentigo maligna with 5% imiquimod cream

C. J. Fleming, A. M. Bryden, A. Evans, R. S. Dawe, S. H. Ibbotson

Research output: Contribution to journal › Article › peer-review

92 Citations (Scopus)

Abstract

Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.

Original language	English
Pages (from-to)	485-488
Number of pages	4
Journal	The British journal of dermatology
Volume	151
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2133.2004.05983.x
Publication status	Published - Aug 2004

Keywords

Aminoquinolines
Hutchinson's Melanotic Freckle
Antineoplastic Agents
Humans
Adult
Treatment Outcome
Aged
Pilot Projects
Middle Aged
Skin Neoplasms
Administration, Topical

Access to Document

10.1111/j.1365-2133.2004.05983.x

http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291365-2133

Cite this

@article{0936318210574f489ac7910d428cbbd5,

title = "A pilot study of treatment of lentigo maligna with 5% imiquimod cream",

abstract = "Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.",

keywords = "Aminoquinolines, Hutchinson's Melanotic Freckle, Antineoplastic Agents, Humans, Adult, Treatment Outcome, Aged, Pilot Projects, Middle Aged, Skin Neoplasms, Administration, Topical",

author = "Fleming, {C. J.} and Bryden, {A. M.} and A. Evans and Dawe, {R. S.} and Ibbotson, {S. H.}",

year = "2004",

month = aug,

doi = "10.1111/j.1365-2133.2004.05983.x",

language = "English",

volume = "151",

pages = "485--488",

journal = "The British journal of dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - A pilot study of treatment of lentigo maligna with 5% imiquimod cream

AU - Fleming, C. J.

AU - Bryden, A. M.

AU - Evans, A.

AU - Dawe, R. S.

AU - Ibbotson, S. H.

PY - 2004/8

Y1 - 2004/8

N2 - Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.

AB - Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.

KW - Aminoquinolines

KW - Hutchinson's Melanotic Freckle

KW - Antineoplastic Agents

KW - Humans

KW - Adult

KW - Treatment Outcome

KW - Aged

KW - Pilot Projects

KW - Middle Aged

KW - Skin Neoplasms

KW - Administration, Topical

U2 - 10.1111/j.1365-2133.2004.05983.x

DO - 10.1111/j.1365-2133.2004.05983.x

M3 - Article

C2 - 15327559

SN - 0007-0963

VL - 151

SP - 485

EP - 488

JO - The British journal of dermatology

JF - The British journal of dermatology

IS - 2

ER -

A pilot study of treatment of lentigo maligna with 5% imiquimod cream

Abstract

Keywords

Access to Document

Fingerprint

Cite this